Dr. Laura A. King, MD

Dr. King practices at Southern California Dermatology in Los Alamitos, California.

Dr. King's NPI, 1487623948, was assigned on March 16, 2006. Dr. King graduated from David Geffen School of Medicine at UCLA in 1975. Dr. King's California license number on file is G32685.

Dr. King's primary practice is Southern California Dermatology, at 4281 Katella Ave, Los Alamitos, CA 90720 in Orange County. The practice phone is (949) 644-0101.

Dr. King's primary practice is Southern California Dermatology in Los Alamitos, California. The medical group on file is West Dermatology. Dmand AI also links Dr. King to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. King practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. King's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. King is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. King's licenses on file in 2 states: California and New Jersey.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. King treats.

CMS data shows 1,075 Medicare services from Dr. King across 9 procedure codes in 2024, for 214 Medicare patients. Medicare paid $51,519 for them. Every service was in an office.

CMS counts 214 Medicare patients who saw Dr. King in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. King's median patient age at 67, with 68% women.

In 2024, Dr. King wrote 253 Medicare Part D claims for 86 patients. 96% of them were for generic drugs. CMS names the drug for 187 of them, across 7 drugs with 11 or more claims each, at $5,351 in total drug cost. In 2023, CMS named 159 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. King for performance year 2024, reported as part of a group. Dr. King accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 355 procedures of removal of skin lesions by Dr. King, more than 83% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. King, published from 2010 to 2020. 2011 was the busiest year, with 2. The most frequent topics are Affect, Adaptation, Psychological and Self Concept. Dr. King has published most often in J Pers Soc Psychol.

CMS Open Payments shows 144 general payments to Dr. King from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $510.

Dmand AI lists 1 award for Dr. King.

Dr. King graduated from David Geffen School of Medicine at UCLA in 1975. Dr. King is a member of AAD.

Dr. King is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.